Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators. Quintero E, et al. N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895. N Engl J Med. 2012. PMID: 22356323 Free article. Clinical Trial.
Economic evaluation of colorectal cancer (CRC) screening.
Cruzado J, Sánchez FI, Abellán JM, Pérez-Riquelme F, Carballo F. Cruzado J, et al. Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):867-80. doi: 10.1016/j.bpg.2013.09.004. Epub 2013 Sep 27. Best Pract Res Clin Gastroenterol. 2013. PMID: 24182607 Review.
Effect of oral anticoagulants on the outcome of faecal immunochemical test.
Bujanda L, Sarasqueta C, Lanas Á, Quintero E, Cubiella J, Hernandez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Portillo I, Jover R, Balaguer F, Cosme A, Castells A; COLONPREV study investigators. Bujanda L, et al. Br J Cancer. 2014 Mar 4;110(5):1334-7. doi: 10.1038/bjc.2014.38. Epub 2014 Feb 4. Br J Cancer. 2014. PMID: 24496455 Free PMC article. Clinical Trial.
Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.
Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X; COLONPREV Study Investigators. Castells A, et al. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1708-16.e4. doi: 10.1016/j.cgh.2014.03.022. Epub 2014 Mar 27. Clin Gastroenterol Hepatol. 2014. PMID: 24681078 Clinical Trial.
Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.
Pérez-Cuadrado-Robles E, Torrella-Cortés E, Bebia-Conesa P, Quesada-Vázquez N, Rodrigo-Agudo JL, Chacón-Martínez S, López-Martín A, Esteban-Delgado P, Pérez-Cuadrado-Martínez E, Pérez-Riquelme F. Pérez-Cuadrado-Robles E, et al. Dig Endosc. 2016 May;28(4):450-455. doi: 10.1111/den.12570. Epub 2015 Dec 9. Dig Endosc. 2016. PMID: 26538148
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.
Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella J, Hernandez V, Mao CG, Perez E, Salas D, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X; COLONPREV study investigators. Alvarez-Urturi C, et al. Dig Liver Dis. 2016 May;48(5):542-551. doi: 10.1016/j.dld.2016.02.001. Epub 2016 Feb 9. Dig Liver Dis. 2016. PMID: 26936343
Implementation of colorectal cancer screening in Spain: main results 2006-2011.
Salas Trejo D, Portillo Villares I, Espinàs Piñol JA, Ibáñez Cabanell J, Vanaclocha Espí M, Pérez Riquelme F, de la Vega Prieto M, González de Aledo Linos Á, Idígoras Rubio I, Sacristán Terroba B, López García R, Romero Hergueta C; Spanish Cancer Screening Network. Salas Trejo D, et al. Eur J Cancer Prev. 2017 Jan;26(1):17-26. doi: 10.1097/CEJ.0000000000000232. Eur J Cancer Prev. 2017. PMID: 27167150
[Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain].
Portillo Villares I, Arana-Arri E, Idigoras Rubio I, Espinás Piñol JA, Pérez Riquelme F, de la Vega Prieto M, González Aledo A, Oceja Setien E, Vanaclocha Espi M, Ibáñez Cabanell J, Salas Trejo D; Grupo CRIBEA. Portillo Villares I, et al. Rev Esp Salud Publica. 2017 Feb 20;91:e201701021. Rev Esp Salud Publica. 2017. PMID: 28218734 Free article. Spanish.
Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M, Ibáñez J, Molina-Barceló A, Pérez E, Nolasco A, Font R, Pérez-Riquelme F, de la Vega M, Arana-Arri E, Oceja M, Espinàs JA, Portillo I, Salas D; CRIBEA Group. Vanaclocha-Espi M, et al. Among authors: perez riquelme f. Prev Med. 2017 Dec;105:190-196. doi: 10.1016/j.ypmed.2017.08.019. Epub 2017 Sep 5. Prev Med. 2017. PMID: 28887191
32 results